The Christie trials pioneering pre-surgery treatment for brain tumours
The POBIG study represents an important and significant milestone in brain cancer research Read More

The POBIG study represents an important and significant milestone in brain cancer research Read More
To mark World Cancer Day on the 4th February, Dr Suzanne Johnson, asked people from across the MCRC how their research is helping to close the cancer care gap. Read More
We speak to Prof. Rob Bristow who speaks about his prostate cancer research and answers the question: Is globalisation the future of cancer research? Read More
Dr Martin McCabe at the University of Manchester and The Christie NHS Foundation Trust, will benefit from an award of more than £200,000 from the Bone Cancer Research Trust to support an international clinical trial for Ewing sarcoma patients. Read More
Funding for experimental therapies, diving deep into science at the CRUK Manchester Centre and a new photography exhibit close an eventful beginning of 2023 for the MCRC Read More
The major funding investment of more than £3m aims to provide future hope for people diagnosed with the disease. Read More
A rare variant of a protein present in nearly all human cells may hold the key to improving the effectiveness of breast cancer treatment, according to University of Manchester research funded by Breast Cancer Now. Read More
Our summary of the conference held between 15th-17th November which covered all aspects of basic, translational and clinical lung cancer research. Read More
Reflecting on the last two months of 2022, Rob looks back on the MCRC International Advisory Board, Director's Lecture with Prof. Karen Knudsen and events in Early Detection. Read More
2022 saw the reintroduction of many face-to-face events and marked the first in-person MB-PhD symposium at the University of Cambridge since 2019. Joanne Oke speaks of her experience of the event. Read More
From the 18th to the 19th October 2022, members of the MCRC Operations Team had the pleasure of attending the Greater Manchester Cancer Conference, held at the Deansgate Hilton Hotel. Read More
As the building reaches its completion, Professor Nic Jones, Director of Strategic Initiatives at the MCRC provides the most recent updates. Read More
We speak to Mengying Wang, a new PhD student from China, who was successfully appointed to the programme following the March 2022 recruitment cycle. Read More
Cancer Research UK, The University of Manchester and Roche Products Ltd (‘Roche’) have opened a multi-drug, precision medicine trial for people with rare cancers who need more treatment options. Read More